Eledon Pharmaceuticals (ELDN) Current Leases (2019 - 2026)
Eledon Pharmaceuticals (ELDN) reported Current Leases of $369000.0 for Q1 2026, up 13.54% on a YoY basis from $325000.0 in Q1 2025, and up 3.07% quarter-over-quarter from $358000.0 in Q4 2025.
Eledon Pharmaceuticals (ELDN) Current Leases (2019 - 2026) Analysis & Trends
Eledon Pharmaceuticals has reported Current Leases for 8 years, with the latest figure at $369000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 13.54% year-over-year to $369000.0; the trailing twelve-month figure through Mar 2026 stood at $369000.0 (up 13.54% YoY), and the FY2025 full-year result was $358000.0, up 14.01% from the prior year.
- Current Leases for Q1 2026 stood at $369000.0, up from $358000.0 in the prior quarter.
- The five-year high for Current Leases was $396000.0 in Q3 2023, with the low at $186000.0 in Q3 2024.
- Historically, Current Leases has averaged $335058.8 across 5 years, with a median of $346000.0 in 2025.
- Annual changes were most pronounced in 2022 — Current Leases soared 238.14% — and 2024, when it sank 53.03%.
- Eledon Pharmaceuticals' Current Leases stood at $363000.0 in 2022, then advanced by 5.51% to $383000.0 in 2023, then fell by 18.02% to $314000.0 in 2024, then increased by 14.01% to $358000.0 in 2025, then grew by 3.07% to $369000.0 in 2026.
- The last three Current Leases figures came in at $369000.0 (Q1 2026), $358000.0 (Q4 2025), and $346000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Eledon Pharmaceuticals | 439.58 Mn | 223.54 Mn | - | 369,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 369,000.00 |
| Dec 31, 2025 | 358,000.00 |
| Sep 30, 2025 | 346,000.00 |
| Jun 30, 2025 | 336,000.00 |
| Mar 31, 2025 | 325,000.00 |
| Dec 31, 2024 | 314,000.00 |
| Sep 30, 2024 | 186,000.00 |
| Jun 30, 2024 | 269,000.00 |
| Mar 31, 2024 | 284,000.00 |
| Dec 31, 2023 | 383,000.00 |
| Sep 30, 2023 | 396,000.00 |
| Jun 30, 2023 | 390,000.00 |
| Mar 31, 2023 | 384,000.00 |
| Dec 31, 2022 | 363,000.00 |
| Sep 30, 2022 | 378,000.00 |
| Jun 30, 2022 | 287,000.00 |
| Mar 31, 2022 | 328,000.00 |
| Dec 31, 2021 | 369,000.00 |
| Sep 30, 2021 | 177,000.00 |
| Jun 30, 2021 | 179,000.00 |